文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

中枢5-羟色胺能系统的放射性示踪剂

Radiotracers for the Central Serotoninergic System.

作者信息

Mangeant Reynald, Dubost Emmanuelle, Cailly Thomas, Collot Valérie

机构信息

Centre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), UNICAEN, Normandie Univ., 14000 Caen, France.

Institut Blood and Brain @ Caen Normandie (BB@C), Boulevard Henri Becquerel, 14000 Caen, France.

出版信息

Pharmaceuticals (Basel). 2022 May 3;15(5):571. doi: 10.3390/ph15050571.

DOI:10.3390/ph15050571

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9143978/

Abstract

This review lists the most important radiotracers described so far for imaging the central serotoninergic system. Single-photon emission computed tomography and positron emission tomography radiotracers are reviewed and critically discussed for each receptor.

摘要

本综述列出了迄今为止描述的用于中枢5-羟色胺能系统成像的最重要的放射性示踪剂。对每种受体的单光子发射计算机断层扫描和正电子发射断层扫描放射性示踪剂进行了综述并严格讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/b4602ae68bc2/pharmaceuticals-15-00571-g023.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/10432795e13b/pharmaceuticals-15-00571-g001.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/8a48a97daf45/pharmaceuticals-15-00571-g002.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/071e2891a83e/pharmaceuticals-15-00571-g003.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/983710437e2e/pharmaceuticals-15-00571-g004.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/e186a7b94d63/pharmaceuticals-15-00571-g005.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/91fe230dbdc1/pharmaceuticals-15-00571-g006.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/409915fb9044/pharmaceuticals-15-00571-g007.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/2b7df26cbc97/pharmaceuticals-15-00571-g008.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/41e51dd4dc4a/pharmaceuticals-15-00571-g009.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/405a6c340db0/pharmaceuticals-15-00571-g010.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/7d8af005013c/pharmaceuticals-15-00571-g011.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/842261dac322/pharmaceuticals-15-00571-g012.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/24c1c09c44a3/pharmaceuticals-15-00571-g013.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/b0432235fc21/pharmaceuticals-15-00571-g014.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/4f1f3d9f1dde/pharmaceuticals-15-00571-g015.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/1287b9a0d9f5/pharmaceuticals-15-00571-g016.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/9b33713e5fdd/pharmaceuticals-15-00571-g017.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/72ce46f49a6a/pharmaceuticals-15-00571-g018.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/b8ca56148a78/pharmaceuticals-15-00571-g019.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/b68191428179/pharmaceuticals-15-00571-g020.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/d1598c659d54/pharmaceuticals-15-00571-g021.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/ea948bc5d3ed/pharmaceuticals-15-00571-g022.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/b4602ae68bc2/pharmaceuticals-15-00571-g023.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/10432795e13b/pharmaceuticals-15-00571-g001.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/8a48a97daf45/pharmaceuticals-15-00571-g002.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/071e2891a83e/pharmaceuticals-15-00571-g003.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/983710437e2e/pharmaceuticals-15-00571-g004.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/e186a7b94d63/pharmaceuticals-15-00571-g005.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/91fe230dbdc1/pharmaceuticals-15-00571-g006.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/409915fb9044/pharmaceuticals-15-00571-g007.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/2b7df26cbc97/pharmaceuticals-15-00571-g008.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/41e51dd4dc4a/pharmaceuticals-15-00571-g009.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/405a6c340db0/pharmaceuticals-15-00571-g010.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/7d8af005013c/pharmaceuticals-15-00571-g011.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/842261dac322/pharmaceuticals-15-00571-g012.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/24c1c09c44a3/pharmaceuticals-15-00571-g013.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/b0432235fc21/pharmaceuticals-15-00571-g014.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/4f1f3d9f1dde/pharmaceuticals-15-00571-g015.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/1287b9a0d9f5/pharmaceuticals-15-00571-g016.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/9b33713e5fdd/pharmaceuticals-15-00571-g017.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/72ce46f49a6a/pharmaceuticals-15-00571-g018.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/b8ca56148a78/pharmaceuticals-15-00571-g019.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/b68191428179/pharmaceuticals-15-00571-g020.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/d1598c659d54/pharmaceuticals-15-00571-g021.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/ea948bc5d3ed/pharmaceuticals-15-00571-g022.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c3/9143978/b4602ae68bc2/pharmaceuticals-15-00571-g023.jpg

相似文献

1

Radiotracers for the Central Serotoninergic System.中枢5-羟色胺能系统的放射性示踪剂

Pharmaceuticals (Basel). 2022 May 3;15(5):571. doi: 10.3390/ph15050571.

2

Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination?用于血清素转运体的有效 PET 和 SPECT 成像剂的开发：二十年的旅程是否已经到达目的地？

Curr Top Med Chem. 2010;10(15):1499-526. doi: 10.2174/156802610793176792.

3

Radiotracers for imaging of Parkinson's disease.用于帕金森病成像的放射性示踪剂。

Eur J Med Chem. 2019 Mar 15;166:75-89. doi: 10.1016/j.ejmech.2019.01.029. Epub 2019 Jan 14.

4

Myocardial Perfusion Scan心肌灌注扫描

5

Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.杂项癌症（肺癌、甲状腺癌、肾癌、骨髓瘤和神经内分泌肿瘤）：SPECT 和 PET 在骨转移成像中的作用。

Semin Nucl Med. 2009 Nov;39(6):416-30. doi: 10.1053/j.semnuclmed.2009.07.002.

6

Targeted nuclear imaging of breast cancer: status of radiotracer development and clinical applications.乳腺癌的靶向核医学影像：放射性示踪剂研发和临床应用现状。

Cancer Biother Radiopharm. 2012 Mar;27(2):105-12. doi: 10.1089/cbr.2011.1025. Epub 2011 Aug 30.

7

Positron emission tomography and single-photon emission computed tomography in central nervous system drug development.正电子发射断层扫描和单光子发射计算机断层扫描在中枢神经系统药物研发中的应用

NeuroRx. 2005 Apr;2(2):226-36. doi: 10.1602/neurorx.2.2.226.

8

Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 1: Technical Considerations and Perfusion and Neuronal Imaging.用于满足心血管成像中未满足临床需求的放射性示踪剂，第1部分：技术考量以及灌注和神经成像

J Nucl Med. 2022 May;63(5):649-658. doi: 10.2967/jnumed.121.263506.

9

Dual-radiotracer translational SPECT neuroimaging. Comparison of three methods for the simultaneous brain imaging of D and 5-HT receptors.双放射性示踪剂转化 SPECT 神经影像学。三种同时脑成像 D 和 5-HT 受体方法的比较。

Neuroimage. 2018 Aug 1;176:528-540. doi: 10.1016/j.neuroimage.2018.04.063. Epub 2018 Apr 30.

10

SPECT and PET Radiotracers in Renal Imaging.SPECT 和 PET 放射性示踪剂在肾脏成像中的应用。

Semin Nucl Med. 2022 Jul;52(4):406-418. doi: 10.1053/j.semnuclmed.2021.12.003. Epub 2022 Jan 19.

引用本文的文献

1

Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics.G 蛋白偶联受体的无配体信号转导：生理学、药理学和遗传学。

Molecules. 2023 Aug 31;28(17):6375. doi: 10.3390/molecules28176375.

本文引用的文献

1

[F]F13640, a 5-HT Receptor Radiopharmaceutical Sensitive to Brain Serotonin Fluctuations.[F]F13640，一种对脑血清素波动敏感的5-羟色胺受体放射性药物。

Front Neurosci. 2021 Mar 8;15:622423. doi: 10.3389/fnins.2021.622423. eCollection 2021.

2

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.国际基础和临床药理学联合会。CX. 5-羟色胺受体分类：药理学与功能。

Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552.

3

Preclinical validation of [F]2FNQ1P as a specific PET radiotracer of 5-HT receptors in rat, pig, non-human primate and human brain tissue.

在大鼠、猪、非人灵长类动物和人脑组织中，对[F]2FNQ1P 作为 5-HT 受体特异性 PET 放射性示踪剂进行临床前验证。

Nucl Med Biol. 2020 Mar-Apr;82-83:57-63. doi: 10.1016/j.nucmedbio.2020.01.006. Epub 2020 Jan 22.

4

A positron emission tomography occupancy study of brexpiprazole at dopamine D and D and serotonin 5-HT and 5-HT receptors, and serotonin reuptake transporters in subjects with schizophrenia.一项针对精神分裂症患者的苯丁哌嗪在多巴胺 D 和 D、血清素 5-HT 和 5-HT 受体以及血清素再摄取转运体上占有率的正电子发射断层扫描研究。

Neuropsychopharmacology. 2020 Apr;45(5):786-792. doi: 10.1038/s41386-019-0590-6. Epub 2019 Dec 17.

5

Potential for imaging the high-affinity state of the 5-HT receptor: a comparison of three PET radioligands with differing intrinsic activity.对5-羟色胺受体高亲和力状态进行成像的潜力：三种具有不同内在活性的正电子发射断层扫描放射性配体的比较。

EJNMMI Res. 2019 Nov 21;9(1):100. doi: 10.1186/s13550-019-0570-1.

6

Serotonin release measured in the human brain: a PET study with [C]CIMBI-36 and d-amphetamine challenge.在人类大脑中测量的血清素释放：使用 [C]CIMBI-36 和 d-苯丙胺挑战的 PET 研究。

Neuropsychopharmacology. 2020 Apr;45(5):804-810. doi: 10.1038/s41386-019-0567-5. Epub 2019 Nov 12.

7

Development of a F-labeled PET radioligand for imaging 5-HT receptors: [F]AZ10419096.用于成像 5-HT 受体的 F-标记 PET 放射性配体的开发：[F]AZ10419096。

Nucl Med Biol. 2019 Nov-Dec;78-79:11-16. doi: 10.1016/j.nucmedbio.2019.10.003. Epub 2019 Oct 22.

8

Radiosynthesis and preclinical evaluation of [ C]Cimbi-701 - Towards the imaging of cerebral 5-HT receptors.[ C]Cimbi-701 的放射性合成与临床前评估 - 迈向大脑 5-HT 受体成像。

J Labelled Comp Radiopharm. 2020 Feb;63(2):46-55. doi: 10.1002/jlcr.3808. Epub 2020 Jan 6.

9

Towards selective CNS PET imaging of the 5-HT receptor system: Past, present and future.迈向5-羟色胺受体系统的选择性中枢神经系统正电子发射断层显像：过去、现在与未来

Neuropharmacology. 2020 Aug 1;172:107830. doi: 10.1016/j.neuropharm.2019.107830. Epub 2019 Oct 24.

10

F-F13640 PET imaging of functional receptors in humans.F-F13640对人类功能性受体的正电子发射断层显像（PET）成像。

Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):220-221. doi: 10.1007/s00259-019-04473-7. Epub 2019 Aug 14.